Abstract
Clostridium difficile infection has a significant impact on patients. It is the most common cause of healthcare-associated infection in hospital and the number one cause of antibiotic-induced diarrhea. C. difficile infection is associated with high morbidity and mortality rate in particular among elderly population and immunocompromised patients. Operative management is still the gold standard in severe and complicated cases, which in itself is associated with significant morbidity and mortality.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Hall I, O’Toole E. Intestinal flora in new-born infants with a description of a new pathogenic anaerobe, Bacillus difficilis. Am J Dis Child. 1935;49:390–402.
Poli A, Di Matteo S, Bruno GM, Fornai E, Valentino MC, Colombo GL. Economic burden of Clostridium difficile in five hospitals of the Florence health care system in Italy. Risk Manag Healthc Policy. 2015;8:207–13.
Li X, Wilson M, Nylander W, Smith T, Lynn M, Gunnar W. Analysis of morbidity and mortality outcomes in postoperative clostridium difficile infection in the veterans health administration. JAMA Surg. 2016;151(4):314–22.
Di Bella S, Ascenzi P, Siarakas S, Petrosillo N, di Masi A. Clostridium difficile toxins A and B: insights into pathogenic properties and extraintestinal effects. Toxins. 2016;8(5):134.
Clabots CR, Johnson S, Olson MM, Peterson LR, Gerding DN. Acquisition of Clostridium difficile by hospitalized patients: evidence for colonized new admissions as a source of infection. J Infect Dis. 1992;166(3):561–7.
Smith LD, King EO. Occurrence of Clostridium difficile in infections of man. J Bacteriol. 1962;84:65–7.
Hafiz S, Oakley CL. Clostridium difficile: isolation and characteristics. J Med Microbiol. 1976;9(2):129–36.
George RH, Symonds JM, Dimock F, Brown JD, Arabi Y, Shinagawa N, et al. Identification of clostridium difficile as a cause of pseudomembranous colitis. Br Med J. 1978;1(6114):695.
Kappas A, Shinagawa N, Arabi Y, Thompson H, Burdon D, Dimock F, et al. Diagnosis of pseudomembranous colitis. Br Med J. 1978;1(6114):675–8.
Talbot RW, Walker RC, Beart RW. Changing epidemiology, diagnosis, and treatment of Clostridium difficile toxin-associated colitis. Br J Surg. 1986;73(6):457–60.
Smits WK, Lyras D, Lacy DB, Wilcox MH, Kuijper EJ. Clostridium difficile infection. Nat Rev Dis Primers. 2016;2:16020.
Chitnis AS, Holzbauer SM, Belflower RM, Winston LG, Bamberg WM, Lyons C, et al. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011. JAMA Intern Med. 2013;173(14):1359–67.
Burnham CA, Carroll KC. Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories. Clin Microbiol Rev. 2013;26(3):604–30.
Burnham CA, Dubberke ER, Kociolek LK, Polage CR, Riley TV. Clostridium difficile-diagnostic and clinical challenges. Clin Chem. 2016;62(2):310–4.
Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013;108(4):478–98. quiz 99
Debast SB, Bauer MP, Kuijper EJ. Diseases ESoCMaI. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2014;20(Suppl 2):1–26.
Kautza B, Zuckerbraun BS. The surgical management of complicated clostridium difficile infection: alternatives to colectomy. Surg Infect. 2016;17(3):337–42.
Ogielska M, Lanotte P, Le Brun C, Valentin AS, Garot D, Tellier AC, et al. Emergence of community-acquired Clostridium difficile infection: the experience of a French hospital and review of the literature. Int J Infect Dis. 2015;37:36–41.
Keller PM, Weber MH. Rational therapy of clostridium difficile infections. Viszeralmedizin. 2014;30(5):304–9.
Kociolek LK, Bovee M, Carter D, Ciolino JD, Patel R, O'Donnell A, et al. Impact of a healthcare provider educational intervention on frequency of clostridium difficile polymerase chain reaction testing in children: a segmented regression analysis. J Pediatric Infect Dis Soc. 2016;6(2):142–8.
Lübbert C. Antimicrobial therapy of acute diarrhoea: a clinical review. Expert Rev Anti-Infect Ther. 2016;14(2):193–206.
Ofosu A. Clostridium difficile infection: a review of current and emerging therapies. Ann Gastroenterol. 2016;29(2):147–54.
Ash L, Baker ME, O’Malley CM, Gordon SM, Delaney CP, Obuchowski NA. Colonic abnormalities on CT in adult hospitalized patients with Clostridium difficile colitis: prevalence and significance of findings. AJR Am J Roentgenol. 2006;186(5):1393–400.
Lübbert C, John E, von Müller L. Clostridium difficile infection: guideline-based diagnosis and treatment. Dtsch Arztebl Int. 2014;111(43):723–31.
Luciano JA, Zuckerbraun BS. Clostridium difficile infection: prevention, treatment, and surgical management. Surg Clin North Am. 2014;94(6):1335–49.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG
About this chapter
Cite this chapter
Alkhamesi, N.A. (2018). Fulminant Clostridium difficile Colitis: Indications and Extent of Surgery. In: Schlachta, C., Sylla, P. (eds) Current Common Dilemmas in Colorectal Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-70117-2_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-70117-2_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-70116-5
Online ISBN: 978-3-319-70117-2
eBook Packages: MedicineMedicine (R0)